Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 1
2007 1
2008 2
2009 1
2010 7
2011 4
2012 2
2013 2
2014 3
2015 1
2016 3
2017 4
2018 4
2019 3
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data.
Winkel P, Hilden J, Jakobsen JC, Lindschou J, Jensen GB, Kjøller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Ärnlöv J, Bjerre M, Gluud C. Winkel P, et al. Among authors: kjoller e. Clin Chem Lab Med. 2021 Aug 12;59(11):1852-1860. doi: 10.1515/cclm-2021-0333. Print 2021 Oct 26. Clin Chem Lab Med. 2021. PMID: 34384145
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.
Winkel P, Jakobsen JC, Hilden J, Jensen GB, Kjøller E, Sajadieh A, Kastrup J, Kolmos HJ, Iversen KK, Bjerre M, Larsson A, Ärnlöv J, Gluud C. Winkel P, et al. Among authors: kjoller e. BMJ Open. 2020 Aug 20;10(8):e033720. doi: 10.1136/bmjopen-2019-033720. BMJ Open. 2020. PMID: 32819979 Free PMC article. Clinical Trial.
Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
Bjerre M, Hilden J, Winkel P, Jensen GB, Kjøller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Ärnlöv J, Jakobsen JC, Gluud C. Bjerre M, et al. Among authors: kjoller e. Atherosclerosis. 2020 May;301:8-14. doi: 10.1016/j.atherosclerosis.2020.03.030. Epub 2020 Apr 4. Atherosclerosis. 2020. PMID: 32289619
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.
Schroder J, Jakobsen JC, Winkel P, Hilden J, Jensen GB, Sajadieh A, Larsson A, Ärnlöv J, Harutyunyan M, Johansen JS, Kjøller E, Gluud C, Kastrup J. Schroder J, et al. Among authors: kjoller e. J Am Heart Assoc. 2020 Mar 3;9(5):e014634. doi: 10.1161/JAHA.119.014634. Epub 2020 Mar 2. J Am Heart Assoc. 2020. PMID: 32114892 Free PMC article. Clinical Trial.
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study.
Nilsson E, Kastrup J, Sajadieh A, Boje Jensen G, Kjøller E, Kolmos HJ, Wuopio J, Nowak C, Larsson A, Jakobsen JC, Winkel P, Gluud C, Iversen KK, Ärnlöv J, Carlsson AC. Nilsson E, et al. Among authors: kjoller e. J Clin Med. 2020 Jan 18;9(1):265. doi: 10.3390/jcm9010265. J Clin Med. 2020. PMID: 31963719 Free PMC article.
Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy.
Schultz M, Rasmussen LJH, Høi-Hansen T, Kjøller E, Jensen BN, Lind MN, Ravn L, Kallemose T, Lange T, Køber L, Rasmussen LS, Eugen-Olsen J, Iversen KK. Schultz M, et al. Among authors: kjoller e. Dis Markers. 2019 May 19;2019:3403549. doi: 10.1155/2019/3403549. eCollection 2019. Dis Markers. 2019. PMID: 31236143 Free PMC article. Clinical Trial.
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial.
Schultz M, Rasmussen LJH, Kallemose T, Kjøller E, Lind MN, Ravn L, Lange T, Køber L, Rasmussen LS, Eugen-Olsen J, Iversen K. Schultz M, et al. Among authors: kjoller e. Scand J Trauma Resusc Emerg Med. 2019 Apr 11;27(1):43. doi: 10.1186/s13049-019-0621-7. Scand J Trauma Resusc Emerg Med. 2019. PMID: 30975178 Free PMC article. Clinical Trial.
Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
Ruge T, Carlsson AC, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, Jakobsen JC, Winkel P, Gluud C, Ärnlöv J. Ruge T, et al. Among authors: kjoller e. Atherosclerosis. 2019 May;284:202-208. doi: 10.1016/j.atherosclerosis.2019.02.031. Epub 2019 Mar 3. Atherosclerosis. 2019. PMID: 30959314 Clinical Trial.
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
Wuopio J, Hilden J, Bring C, Kastrup J, Sajadieh A, Jensen GB, Kjøller E, Kolmos HJ, Larsson A, Jakobsen JC, Winkel P, Gluud C, Carlsson AC, Ärnlöv J. Wuopio J, et al. Among authors: kjoller e. Atherosclerosis. 2018 Nov;278:97-102. doi: 10.1016/j.atherosclerosis.2018.09.006. Epub 2018 Sep 15. Atherosclerosis. 2018. PMID: 30261474 Clinical Trial.
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course.
Winkel P, Jakobsen JC, Hilden J, Jensen G, Kjøller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Ärnlöv J, Gluud C. Winkel P, et al. Among authors: kjoller e. Open Heart. 2018 Sep 5;5(2):e000808. doi: 10.1136/openhrt-2018-000808. eCollection 2018. Open Heart. 2018. PMID: 30228904 Free PMC article.
40 results